Iterum ITRM Stalls at 003 Consolidation Phase 20260515 PM Modi Begins Norway Visit Trade Technology and Arctic Cooperation in Focus Bronstein Gewirtz Grossman Announces Class Action Lawsuit Against Pinterest Inc Investors Urged to Act Trump Regrets Not Demanding Larger Intel Stake as US Government Investment Soars Stolen Identities Emerge as Primary Driver of Cyberattack Surge Global Oil Supply Disruptions Reshape Energy Demand Patterns Corn Futures End Week on Positive Note Supported by Weather and Export Demand Expert Warns Against Buy on Dips Strategy as Market Volatility Persists Says HDFC Securities Devarsh Vakil Sebi Exposes Alleged PumpandDump Scheme Across 82 SME Stocks Impounds Rs 2025 Crore Plus500 Reports 11 Quarterly Revenue Increase Expects to Meet Market Expectations RDNT Q1 2026 Earnings EPS Misses Estimates by Wide Margin PLAG Q3 2023 Earnings Narrowing Losses Amidst Strategic Reorientation EDUC Q1 2026 Earnings Narrowing Loss Highlights Ongoing Restructuring ORLA Q1 2026 Earnings EPS Misses by 054 as Stock Declines CELH Q1 2026 Earnings EPS Surges 355 Above Estimates Driving Stock Higher POWWP Q1 2026 Earnings EPS Surges Past Estimates with 165 Surprise Texas Roadhouse TXRH Gains 26 as Stock Holds Above Key Support LCNB Corporation Holds Steady Near Support as Market Awaits Direction Iveda Solutions Warrants IVDAW Hold Steady at 003 No Momentum in Sight Doximity Inc DOCS Holds Near Support After Modest Decline Quantum Biopharma Ltd QNTM Surges 18 Key Levels and Potential Drivers Chinas New Strategic Blueprint Signals Potential Shift in Global EV and AI Standards Microsoft and Anthropic in Early Talks for Custom AI Chip Deal Following 5 Billion Investment South Koreas Deputy PM Warns AIDriven Wealth Must Benefit Public Amid Samsung Labor Unrest AI Industry Emerges as Key Beneficiary of MuskAltman Trial Proceedings Vestas Wind Systems Shares Slide After Company Flags Margins at Low End of Guidance Applied Digital Secures MultiBillionDollar Hyperscaler Lease for Polaris Forge 3 Campus Analyst Revises Outlook REPL Q1 2026 Earnings Narrower Than Expected Loss but Revenue Remains Elusive Lixte Biotechnology LIXT Slides 525 as Stock Tests Key Support at 532